Previous studies have tested multiple therapeutic combinations with FGF21 or FGF21 alone and have found that FGF21 alone is sufficient to improve insulin sensitivity and reduce obesity in HFD-fed mice (23). The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.